Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Commodore Capital LP | 1,000,000 9.900% |
384,186 (+62.39%) |
Filing History |
| 2024-02-13 7:34 pm Sale |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BANK OF AMERICA CORP BAC |
442,590 4.400% |
-116,600 (-20.85%) |
Filing History |
| 2024-02-12 10:13 am Sale |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
MORGAN STANLEY MS |
515,050 5.100% |
-198,456 (-27.81%) |
Filing History |
| 2024-02-09 11:41 am Purchase |
2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
Frazier Life Sciences Public Fund, L.P. | 1,041,667 11.000% |
1,041,667 (New Position) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
FMR CORP | 612,427 6.062% |
-164,860 (-21.21%) |
Filing History |
| 2024-02-07 11:36 am Sale |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 485,425 2.300% |
-244,593 (-33.51%) |
Filing History |
| 2023-07-24 4:16 pm Purchase |
2023-07-14 | 13G | Adverum Biotechnologies, Inc. ADVM |
Venrock Healthcare Capital Partners III L.P. | 589,949 5.900% |
589,949 (New Position) |
Filing History |
| 2023-04-20 4:05 pm Purchase |
2023-04-10 | 13G | Adverum Biotechnologies, Inc. ADVM |
Commodore Capital LP | 615,814 6.100% |
615,814 (New Position) |
Filing History |
| 2023-02-14 10:20 am Sale |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
RTW Investments, LP | 0 0.000% |
-755,482 (Position Closed) |
Filing History |
| 2023-02-14 09:30 am Sale |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-695,000 (Position Closed) |
Filing History |
| 2023-02-14 08:06 am Sale |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Soleus Capital Master Fund, L.P. | 0 0.000% |
-498,279 (Position Closed) |
Filing History |
| 2023-02-14 07:55 am Purchase |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BANK OF AMERICA CORP BAC |
559,190 5.600% |
559,190 (New Position) |
Filing History |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Adverum Biotechnologies, Inc. ADVM |
FMR CORP | 777,287 7.793% |
-310,098 (-28.52%) |
Filing History |
| 2023-02-08 4:44 pm Purchase |
2023-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 730,018 7.300% |
212,468 (+41.05%) |
Filing History |
| 2023-02-08 2:48 pm Purchase |
2022-12-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
MORGAN STANLEY MS |
713,505 7.200% |
713,505 (New Position) |
Filing History |
| 2022-12-30 4:11 pm Sale |
2022-12-27 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 463,143 4.600% |
-200,000 (-30.16%) |
Filing History |
| 2022-09-02 10:18 am Purchase |
2022-08-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Soleus Capital Master Fund, L.P. | 498,279 5.000% |
498,279 (New Position) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
332,384 3.400% |
-402,298 (-54.76%) |
Filing History |
| 2022-05-10 12:40 pm Purchase |
2022-05-04 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 517,550 5.200% |
517,550 (New Position) |
Filing History |
| 2022-04-11 09:01 am Purchase |
2022-04-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
FMR CORP | 1,087,385 11.011% |
930,157 (+591.60%) |
Filing History |